ritanserin has been researched along with Anterior Choroidal Artery Infarction in 2 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizutani, K | 1 |
| Sonoda, S | 1 |
| Wakita, H | 1 |
| Takagi, K | 1 |
| Ginsberg, MD | 1 |
| Globus, MY | 1 |
| Busto, R | 1 |
| Dietrich, WD | 1 |
2 other studies available for ritanserin and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Ritanserin, a serotonin-2 receptor antagonist, inhibits functional recovery after cerebral infarction.
Topics: Animals; Cerebral Infarction; Disease Models, Animal; GAP-43 Protein; Gene Expression Regulation; Lo | 2018 |
The effect of ritanserin, a 5-HT2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion.
Topics: Animals; Blood Pressure; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Cortex; Cerebral Infarct | 1994 |